Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases: Preliminary results of FOCUS (PHP-OCM-301/301A) phase III trial.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, Evan Scott Glazer, Aslam Ejaz, Erika Richtig, Sebastian Ochsenreither, Michael C. Lowe, Sunil A. Reddy, Georgia Beasley, Anja Gesierich, Reinhard Dummer, Ana Maria Arance, Stephen William Fenwick, Matthew Wheater, Christian Ottensmeier
Institutions: Moffitt Cancer Center, Thomas Jefferson University, European Institute of Oncology, University of Tennessee Health Science Center, The Ohio State University, Medical University of Graz, Stiftung Charité, Charité – Universitätsmedizin Berlin, Emory University, Stanford Cancer Institute, Duke University, Universitätsklinikum Würzburg, University Hospital Zurich, Hospital Clínic de Barcelona, Liverpool University Hospitals NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust, Clatterbridge Cancer Centre NHS Foundation Trust
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3166778631